Effects of bothrops asper snake venom on lymphatic vessels: Insights into a hidden aspect of envenomation

PLoS Neglected Tropical Diseases

Volumn 2, Issue 10, 2008, Pages

  Mora, Javier ^a   Mora, Rodrigo ^a   Lomonte, Bruno ^a   Gutiérrez, José Maria ^a  

^a UNIVERSIDAD DE COSTA RICA   (Costa Rica)

Author keywords

[No Author keywords available]

Indexed keywords

BATIMASTAT; FUCOIDIN; METALLOPROTEINASE; PHOSPHOLIPASE A2; PROPIDIUM IODIDE; SERINE PROTEINASE; SNAKE VENOM; PHOSPHOLIPASE A;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CELL MEMBRANE PERMEABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; ENVENOMATION; FOOT EDEMA; IMAGE ANALYSIS; LYMPH FLOW; LYMPH VESSEL; MESENTERY LYMPH NODE; MICROSCOPY; MOUSE; MUSCLE NECROSIS; NONHUMAN; PATHOGENESIS; SKELETAL MUSCLE; SNAKE; SNAKEBITE; VASOCONSTRICTION; ANIMAL; BLOOD FLOW VELOCITY; CELL LINE; DRUG EFFECT; ENZYMOLOGY; HUMAN; IN VITRO STUDY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SMOOTH MUSCLE FIBER;

ANIMALS; BLOOD FLOW VELOCITY; BOTHROPS; CELL LINE; CROTALID VENOMS; HUMANS; LYMPHATIC VESSELS; MICE; MYOCYTES, SMOOTH MUSCLE; PHOSPHOLIPASES A; SNAKE BITES;

EID: 56149122771     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000318     Document Type: Article

References (64)

1. Chippaux JP (1998) Snake-bites: Appraisal of the global situation. Bull World Health Organ 76: 515-524.
2. Gutiérrez JM, Theakston RD Warrell DA (2006) Confronting the neglected problem of snake bite envenoming: The need for a global partnership. PLoS Med 3: E150. doi:10.1371/journal.pmed.0030150.
3. Warrell DA (1996) Clinical features of envenoming from snake bites. In: Boo C, Goyffon M, eds. Envenomings and Their Treatments. Lyon: Fondation Marcel Mérieux. pp 63-76.
4. WHO (2007) Rabies and envenomings: A neglected public health issue. Report of a consultative meeting: WHO, Geneva.
5. Warrell DA (1995) Clinical toxicology of snakebite in Africa and the Middle East/Arabian peninsula. In: Meier J, White J, eds. Handbook of Clinical Toxicology of Animal Venoms and Poisons. Florida: CRC Press. pp 433-492.
6. Warrell DA (2004) Epidemiology, clinical features and management of snake bites in Central and South America. In: Campbell J, Lamar WW, eds. Venomous Reptiles of the Western Hemisphere. Ithaca: Cornell University Press. pp 709-761.
7. Gutiérrez JM, Lomonte B (2003) Efectos locales en el envenenamiento ofidico en América Latina. In: Cardoso JLC, Franca FOS, Wen FH, Málaque CMS, Haddad V, eds. Animals Peconhentos no Brasil. Biologia, Clínica e Terapeutica. San Paulo: Sarvier. pp 310-323.
8. Fan HW, Cardoso JL (1995) Clinical toxicology of snake bites in South America. In: Meier J, White J, eds. Handbook of Clinical Toxicology of Animal Venoms and Poisons. Florida: CRC Press. pp 667-688.
9. Gutiérrez JM (1995) Clinical toxicology of snakebite in Central America. In: Meier J, White J, eds. Handbook of Clinical Toxicology of Animal Venoms and Poisons. Florida: CRC Press. pp 645-665.
10. Campbell J, Lamar WW (2004) Venomous Reptiles of the Western Hemisphere. Ithaca: Cornell University Press.
11. Bolaños R (1982) Las serpientes venenosas de Centroamérica y el problema del ofidismo. Primera parte. Aspectos zoológicos, epidemiológicos y biomédicos. Revista Costarricense de Ciencias Médicas 3: 165-184.
12. Otero R, Tobón GS, Gómez LF, Osorio RG, Valderrama, et al. (1992) Accidente ofidico en Antioquia y Chocó. Aspectos clínicos y epidemiológicos (marzo de 1989-febrero de 1990). Acta Médica Colombiana 17: 229-249.
13. 2 myotoxins from Bothrops snake venoms. Toxicon 33: 1405-1424.
14. Gutiérrez JM, Rucavado A (2000) Snake venom metalloproteinases: their role in the pathogenesis of local tissue damage. Biochimie 82: 841-850.
15. 2: Insights into the mechanisms of local and systemic myotoxicity. Toxicon 42: 915-931.
16. Fox JW, Serrano SM (2005) Structural considerations of the snake venom metalloproteinases, key members of the M12 reprolysin family of metalloproteinases. Toxicon 45: 969-985.
17. Escalante T, Shannon J, Moura-da-Silva AM, Gutiérrez JM, Fox JW (2006) Novel insights into capillary vessel basement membrane damage by snake venom hemorrhagic metalloproteinases: A biochemical and immunohistochemical study. Arch Biochem Biophys 455: 144-153.
18. Otero R, Gutiérrez J, Mesa MB, Duque E, Rodriguez O, et al. (2002) Complications of Bothrops, Porthidium, and Bothriechis snakebites in Colombia. A clinical and epidemiological study of 39 cases attended in a university hospital. Toxicon 40: 1107-1114.
19. Liu N (2003) Metabolism of macromolecules in tissue. Lymphat Res Biol 1: 67-70.
20. Jeltsch M, Tammela T, Alitalo K, Wilting J (2003) Genesis and pathogenesis of lymphatic vessels. Cell Tissue Res 314: 69-84.
21. Pepper MS (2006) The lymphatic system. In: Shepro D, ed. Microvascular Research. Amsterdam: Elsevier. pp 523-534.
22. Mortimer PS, Levick JR (2004) Chronic peripheral oedema: The critical role of the lymphatic system. Clin Med 4: 448-453.
23. Cueni LN, Detmar M (2006) New insights into the molecular control of the lymphatic vascular system and its role in disease. J Invest Dermatol 126: 2167-2177.
24. Alexander JS (2006) Lymphatic endothelial cells: Heterogeneity from blood endothelium and unique properties in health and disease. In: Shepro D, ed. Microvascular Research. Amsterdam: Elsevier. pp 513-518.
25. Gutiérrez JM, León G, Lomonte B (2003) Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation. Clin Pharmacokinet 42: 721-741.
26. Lomonte B, Gutiérrez JM (1989) A new muscle damaging toxin, myotoxin II, from the venom of the snake Bothrops asper (terciopelo). Toxicon 27: 725-733.
27. Gutiérrez JM, Ownby CL, Odell GV (1984) Isolation of a myotoxin from Bothrops asper venom: Partial characterization and action on skeletal muscle. Toxicon 22: 115-128.
28. Gutiérrez JM, Romero M, Díaz C, Borkow G, Ovadia M (1995) Isolation and characterization of a metalloproteinase with weak hemorrhagic activity from the venom of the snake Bothrops asper (terciopelo). Toxicon 33: 19-29.
29. Rucavado A, Núñez J, Gutiérrez JM (1998) Blister formation and skin damage induced by BaP1, a haemorrhagic metalloproteinase from the venom of the snake Bothrops asper. Int J Exp Pathol 79: 245-254.
30. Pérez AV, Rucavado A, Sanz L, Calvete JJ, Gutiérrez JM (2008) Isolation and characterization of a serine proteinase with thrombin-like activity from the venom of the snake Bothrops asper. Braz J Med Biol Res 41: 12-17.
31. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
32. Shirasawa Y, Ikomi F, Ohashi T (2000) Physiological roles of endogenous nitric oxide in lymphatic pump activity of rat mesentery in vivo. Am J Physiol Gastrointest Liver Physiol 278: G551-556.
33. Lomonte B, Lundgren J, Johansson B, Bagge U (1994) The dynamics of local tissue damage induced by Bothrops asper snake venom and myotoxin II on mouse cremaster muscle: An intravital and election microscopic study. Toxicon 32: 41-55.
34. Rucavado A, Lomonte B, Ovadia M, Gutiérrez JM (1995) Local tissue damage induced by BaP1, a metalloproteinase isolated from Bothrops asper (terciopelo) snake venom. Exp Mol Pathol 63: 186-199.
35. Moreira L, Gutiérrez JM, Borkow G, Ovadia M (1992) Ultrastructural alterations in mouse capillary blood vessels after experimental injection of venom from the snake Bothrops asper (Terciopelo). Exp Mol Pathol 57: 124-133.
36. Escalante T, Franceschi A, Rucavado A, Gutiérrez JM (2000) Effectiveness of batimastat, a synthetic inhibitor of matrix metalloproteinases, in neutralizing local tissue damage induced by BaP1, a hemorrhagic metalloproteinase from the venom of the snake Bothrops asper. Biochem Pharmacol 60: 269-274.
37. 2EDTA. Am J Trop Med Hyg 63: 313-319.
38. 2. Biochem Pharmacol 66: 1993-2000.
39. Azofeifa K, Angulo Y, Lomonte B (2007) Ability of fucoidan to prevent muscle necrosis induced by snake venom myotoxins: Comparison of high- and low-molecular weight fractions. Toxicon 51: 373-380.
40. Lomonte B, Tarkowski A, Hanson LÅ (1993) Host response to Bothrops asper snake venom. Analysis of edema formation, inflammatory cells, and cytokine release in a mouse model. Inflammation 17: 93-105.
41. Chaves F, Barboza M, Gutiérrez JM (1995) Pharmacological study of edema induced by venom of the snake Bothrops asper (terciopelo) in mice. Toxicon 33: 31-39.
42. 2 isolated from the venom of the snake Bothrops asper (terciopelo). Toxicon 36: 1861-1869.
43. 2 of Bothrops asper snake venom. Toxicon 32: 1359-1369.
44. 2 on mouse endothelial (tEnd) and skeletal muscle (C2C12) cells in vitro. Toxicon 37: 145-158.
45. 2 homologue from the venom of the snake Bothrops asper: Evidence of rapid plasma membrane damage and a dual role for extracellular calcium. Toxicol In Vitro 21: 1382-1389.
46. Schmid-Schonbein GW (2003) The second valve system in lymphatics. Lymphat Res Biol 1: 25-29.
47. Schmid-Schonbein GW (2006) Foundations of microlymphatic function. In: Shepro D, ed. Microvascular Research. Amsterdam: Elsevier. pp 529-534.
48. Hosking B, Makinen T (2007) Lymphatic vasculature: A molecular perspective. Bioessays 29: 1192-1202.
49. Bridenbaugh EA, Gashev AA, Zawieja DC (2003) Lymphatic muscle: A review of contractile function. Lymphat Res Biol 1: 147-158.
50. Shirasawa Y, Benoit JN (2003) Stretch-induced calcium sensitization of rat lymphatic smooth muscle. Am J Physiol Heart Circ Physiol 285: H2573-2577.
51. Gutiérrez JM, Rucavado A, Escalante T, Díaz C (2005) Hemorrhage induced by snake venom metalloproteinases: Biochemical and biophysical mechanisms involved in microvessel damage. Toxicon 45: 997-1011.
52. Alape-Girón A, Sanz L, Escolano J, Flores-Díaz M, Madrigal M, et al. (2008) Snake venomics of the lancehead pitviper Bothrops asper: Geographic, individual, and ontogenetic variations. J Proteome Res 7: 3556-3571.
53. Gutiérrez JM, Chaves F, Bolaños R (1980) Estudio comparativo de venenos de ejemplares recién nacidos y adultos de Bothrops asper. Rev Biol Trop 28: 341-251.
54. Lomonte B, Carmona E (1992) Individual expression patterns of myotoxin isoforms in the venom of the snake Bothrops asper. Comp Biochem Physiol B 102: 325-329.
55. 2 Enzymes. Structure, Function and Mechanism. Chichester: Wiley. pp 321-352.
56. Lomonte B, Gutiérrez JM, Borkow O, Ovadia M, Tarkowski A, Hanson LA (1994) Activity of hemorrhagic metalloproteinase BaH-1 and myotoxin II from Bothrops asper snake venom on capillary endothelial cells in vitro. Toxicon 32: 505-510.
57. Díaz C, Valverde L, Brenes O, Rucavado A, Gutiérrez JM (2005) Characterization of events associated with apoptosis/anoikis induced by snake venom metalloproteinase BaP1 on human endothelial cells. J Cell Biochem 94: 520-528.
58. Gutiérrez JM, Núñez J, Escalante T, Rucavado A (2006) Blood flow is required for rapid endothelial cell damage induced by a snake venom hemorrhagic metalloproteinase. Microvasc Res 71: 55-63.
59. Markland FS (1998) Snake venoms and the hemostatic system. Toxicon 36: 1749-1800.
60. Loría GD, Rucavado A, Kamiguti AS, Theakston RDG, Fox JW, et al. (2003) Characterization of 'basparin A,' a prothrombin-activating metalloproteinase, from the venom of the snake Bothrops asper that inhibits platelet aggregation and induces defibrination and thrombosis. Arch Biochem Biophys 418: 13-24.
61. 2 myotoxins from crotalid snake venoms and their structural determinants of myotoxic action. Toxicon 42: 885-901.
62. 2. Toxicon 42: 947-962.
63. Otero R, Gutiérrez JM, Núñez V, Robles A, Estrada R, et al. (1996) A randomized double-blind clinical trial of two antivenoms in patients bitten by Bothrops alrox in Colombia. Trans R Soc Trop Med Hyg 90: 696-700.
64. Trebien HA, Calixto JB (1989) Pharmacological evaluation of rat paw oedema induced by Bothrops jararaca venom. Agents Actions 26: 292-300.